EZH2 and myelodysplastic syndrome: In patients with MDS, EZH2 mutations are associated with poor prognosis when compared to that of MDS patients with wild-type EZH2. Furthermore, patients with bi-allelic EZH2 mutations showed worse overall survival than those with mono-allelic EZH2 mutations [47].